USPTO serial 79317340
IMMGAP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAN, DAWN L
- Law office
- TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with IMMGAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for production of antibodies and synthetic and natural peptides | ACTIVE | — |
| 005 | Pharmaceutical preparations for human use; veterinary preparations; vaccines; therapeutic medicines; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; antibodies | ACTIVE | — |
| 010 | Delivery systems for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers; syringes for injection and medical purposes | ACTIVE | — |
| 042 | Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; laboratory services related to production of antibodies; research and development in the area of antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 7, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 18, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 17, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 31, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 11, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 11, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 19, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 17, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 17, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 11, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 18, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 17, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 5, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |